Detalles de la búsqueda
1.
Adverse event load, onset, and maximum grade: A novel method of reporting adverse events in cancer clinical trials.
Clin Trials
; 18(1): 51-60, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32998522
2.
Association of post-operative CEA with survival and oxaliplatin benefit in patients with stage II colon cancer: a post hoc analysis of the MOSAIC trial.
Br J Cancer
; 121(4): 312-317, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31296923
3.
MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study.
Lancet Oncol
; 18(2): 192-201, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28094194
4.
BRAF-Mutated Colorectal Cancer: What Is the Optimal Strategy for Treatment?
Curr Treat Options Oncol
; 18(2): 9, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28214977
5.
Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database.
Lancet Oncol
; 17(12): 1709-1719, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27743922
6.
Efficacy of a sequential treatment strategy with GEMOX-based followed by FOLFIRI-based chemotherapy in advanced biliary tract cancers.
Acta Oncol
; 55(9-10): 1168-1174, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27333436
7.
New Therapeutic Opportunities Based on DNA Mismatch Repair and BRAF Status in Metastatic Colorectal Cancer.
Curr Oncol Rep
; 18(3): 18, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26861657
8.
Bevacizumab with or without erlotinib as maintenance therapy in patients with metastatic colorectal cancer (GERCOR DREAM; OPTIMOX3): a randomised, open-label, phase 3 trial.
Lancet Oncol
; 16(15): 1493-1505, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26474518
9.
Ribociclib for HR-Positive, Advanced Breast Cancer.
N Engl J Med
; 376(3): 288-289, 2017 01 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-28102649
10.
STRATEGIC-1: A multiple-lines, randomized, open-label GERCOR phase III study in patients with unresectable wild-type RAS metastatic colorectal cancer.
BMC Cancer
; 15: 496, 2015 Jul 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-26141683
11.
Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer.
Gut
; 63(9): 1416-23, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24162591
12.
Could baseline health-related quality of life (QoL) predict overall survival in metastatic colorectal cancer? The results of the GERCOR OPTIMOX 1 study.
Health Qual Life Outcomes
; 12: 69, 2014 May 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-24886671
13.
A Randomized Phase III Study of Arfolitixorin versus Leucovorin with 5-Fluorouracil, Oxaliplatin, and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer: The AGENT Trial.
Cancer Res Commun
; 4(1): 28-37, 2024 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38059497
14.
Efficacy of immune checkpoint inhibitors for metastatic colorectal cancer with microsatellite instability in second or latter line using synthetic control arms: A non-randomised evaluation.
Eur J Cancer
; 199: 113537, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38241818
15.
Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials.
J Clin Oncol
; : JCO2301326, 2024 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38547438
16.
Prognostic impact of positive surgical margins after resection of colorectal cancer liver metastases: reappraisal in the era of modern chemotherapy.
World J Surg
; 37(11): 2647-54, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23982776
17.
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial.
Lancet Oncol
; 13(12): 1225-33, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23168362
18.
FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study.
J Clin Oncol
; 41(19): 3469-3477, 2023 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37379692
19.
Clinical and exploratory biomarker findings from the MODUL trial (Cohorts 1, 3 and 4) of biomarker-driven maintenance therapy for metastatic colorectal cancer.
Eur J Cancer
; 184: 137-150, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36921494
20.
Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3,369 patients in the ARCAD database.
Eur J Cancer
; 178: 162-170, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36446161